Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Key COVID-19 Studies Influencing My Practice Following IDWeek 2021—Rapid Recap by Arthur Kim, MD

September 29 - October 3, 2021; Virtual
Hear unique insights from expert faculty presenting updates and new COVID-19 data from IDWeek 2021, including prevention, treatment of outpatients and hospitalized patients, and long-term outcomes.
Arthur Kim, MD
Released: October 21, 2021

Information on this Educational Activity

Faculty

Arthur Kim, MD

Associate Professor
Department of Medicine
Harvard Medical School
Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Arthur Kim, MD, has disclosed that he serves on the data and safety monitoring board for a study sponsored by Kintor Pharmaceuticals.

Program Medium

This program has been made available online.

Related Content

Download slides reviewing the latest data and guidance on COVID-19 prevention and treatment in special populations, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: May 18, 2022

Expert insights on new key data from ECCMID 2022 on SARS-CoV-2 and COVID-19, including on diagnosis, prevention, and treatment, as reported by Clinical Care Options (CCO)

Cristina Mussini, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: May 18, 2022 Expired: May 17, 2023

Download slides reviewing the latest data and guidance on COVID-19 symptoms and clinical manifestations, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: May 17, 2022

Downloadable slides from CCO on the rationale and evidence supporting timeliness in the administration of therapies that act directly against SARS-CoV-2

person default Michael G. Ison, MD, MS Arthur Kim, MD Lynora Saxinger, MD, FRCPC, CTropMed Released: May 11, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings